These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 14600027)

  • 1. Murine models of polycystic kidney disease: molecular and therapeutic insights.
    Guay-Woodford LM
    Am J Physiol Renal Physiol; 2003 Dec; 285(6):F1034-49. PubMed ID: 14600027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic kidney disease and therapeutic approaches.
    Park EY; Woo YM; Park JH
    BMB Rep; 2011 Jun; 44(6):359-68. PubMed ID: 21699747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging assessment of a murine model of recessive polycystic kidney disease.
    Sun Y; Zhou J; Stayner C; Munasinghe J; Shen X; Beier DR; Albert MS
    Comp Med; 2002 Oct; 52(5):433-8. PubMed ID: 12405636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic modifiers of polycystic kidney disease in intersubspecific KAT2J mutants.
    Upadhya P; Churchill G; Birkenmeier EH; Barker JE; Frankel WN
    Genomics; 1999 Jun; 58(2):129-37. PubMed ID: 10366444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent advances in molecular pathogenesis and treatment of polycystic kidney disease].
    Covic M; Covic M
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(1):11-20. PubMed ID: 18677899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney.
    Sun Z; Amsterdam A; Pazour GJ; Cole DG; Miller MS; Hopkins N
    Development; 2004 Aug; 131(16):4085-93. PubMed ID: 15269167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of polycystic kidney disease.
    Carone FA; Bacallao R; Kanwar YS
    Histol Histopathol; 1995 Jan; 10(1):213-21. PubMed ID: 7756739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
    Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative trait loci modulate renal cystic disease severity in the mouse bpk model.
    Guay-Woodford LM; Wright CJ; Walz G; Churchill GA
    J Am Soc Nephrol; 2000 Jul; 11(7):1253-1260. PubMed ID: 10864581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pathophysiology of cystic kidney disease: insight into future therapies.
    Avner ED; Woychik RP; Dell KM; Sweeney WE
    Int J Dev Biol; 1999; 43(5):457-61. PubMed ID: 10535324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.
    Gattone VH; MacNaughton KA; Kraybill AL
    Anat Rec; 1996 Jul; 245(3):488-99. PubMed ID: 8800407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models for human polycystic kidney disease.
    Nagao S; Kugita M; Yoshihara D; Yamaguchi T
    Exp Anim; 2012; 61(5):477-88. PubMed ID: 23095811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic kidney disease: new understanding in the pathogenesis.
    Wilson PD
    Int J Biochem Cell Biol; 2004 Oct; 36(10):1868-73. PubMed ID: 15203099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ezrin distribution is abnormal in principal cells from a murine model of autosomal recessive polycystic kidney disease.
    Orellana SA; Quinoñes AM; Mandapat ML
    Pediatr Res; 2003 Sep; 54(3):406-12. PubMed ID: 12840161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease.
    Gattone VH; Maser RL; Tian C; Rosenberg JM; Branden MG
    Dev Genet; 1999; 24(3-4):309-18. PubMed ID: 10322639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice.
    Woo DD; Nguyen DK; Khatibi N; Olsen P
    J Clin Invest; 1997 Oct; 100(8):1934-40. PubMed ID: 9329956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
    Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
    Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.
    Cowley BD
    Drugs; 2004; 64(12):1285-94. PubMed ID: 15200344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.
    Ostrom L; Tang MJ; Gruss P; Dressler GR
    Dev Biol; 2000 Mar; 219(2):250-8. PubMed ID: 10694420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.